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DISCUSSION and FUTURE DIRECTIONS REFERENCES
Results
● Endolysins are proteins produced by 
bacteriophage that break down the 
peptidoglycan cell walls of host bacteria, 
resulting in cell lysis and the release of 
progeny virions (Oliviera et al., 2013)
● Bacteria produce similar proteins called 
autolysins that are important in cell 
division (Cullin et al., 2017)
● Many endolysins have a two domain 
structure with an enzymatically active 
domain (EAD) that cleaves bonds and a 
cell wall binding domain (CBD) that 
anchors the endolysin to the cell wall and 
determines specificity (Linden et al., 
2021)
● Researchers can combine EADs and 
CBDs from different bacteriophage to 
engineer chimeric endolysins, which 
show great promise for treating antibiotic 
resistant bacterial infections (Linden et 
al., 2021)
Figure 1. Generalized Peptidoglycan Structure 
Showing Endolysin Cleavage Sites. Cylinders 
represent sugars and ovals represent amino acids. 
Glycosidic bonds link sugars together, peptide bonds 
link amino acids together, and amide bonds connect 
sugars to amino acids. Retrieved from Oliviera et al., 
2013.
Pal Endolysin
● Produced by Bacteriophage Dp-1, which infects 
Streptococcus pneumoniae bacteria (García et 
al., 1984)
● Pal’s EAD cleaves the bond between 
N-acetylmuramic acid (a sugar) and L-alanine 
(an amino acid) (García et al., 1984)
● Pal’s CBD consists of six choline binding 
repeats (CBRs) (Maestro and Sanz, 2016) and 
ends with a tail that contributes to dimerization 
(Nelson, 2021, personal communication)
● Pal is a natural chimeric endolysin (Sheehan et 
al., 2003)
○ Pal’s EAD is homologous to that of Orf259, 
an amidase produced by Bacteriophage 
BK5-T, which infects Lactobacillus lactis
○ Pal’s CBD is homologous to LytA, an 
autolysin produced by S. pneumoniae
● Pal is effective at killing S. pneumoniae (including 
penicillin resistant strains) both in vitro and in 
mice (Loeffler et al., 2001)
Figure 2. Pal’s Functional Domains. Blue 
blocks represent CBRs. Retrieved from 
Maestro and Sanz, 2016.
Figure 3. The Chimeric Origins of Pal. N 
refers to the EAD. C refers to the CBD. J 
refers to the flexible linker connecting these 
domains. Retrieved from Sheehan et al., 
2003.
Figure 5. Phylogenetic Trees. A. Pal’s EAD is not particularly well 
conserved. As a result, the homologous proteins on the tree come from a 
variety of taxonomically distant bacteria and bacteriophage. Many of these 
proteins are believed to have peptidase activity (orange shaded region). 
Some of the most closely related sequences appear to be amidases like Pal 
(green shaded regions). A substantial portion of the proteins are poorly 
described, hypothetical, or partial, which complicates the phylogenetic 
relationships further. B. The MSA representing Pal’s CBD is shown as a sister 
taxon to a lytic amidase from S. pneumoniae, which on further investigation 
turned out to be an allozyme of LytA, supporting the findings of Sheehan et al. 
(2003) (pink shaded region). Multiple other allozymes of LytA appear in other 
locations on the tree (yellow shaded region). In addition to autolysins, many 
other choline binding proteins and surface proteins from various 
Streptococcus species appear as a clade (green shaded region), suggesting a 


















Phylogenetic Tree of Sequences Homologous to Pal’s Enzymatically Active 
Domain (EAD) [A]
Phylogenetic Tree of Sequences Homologous to Pal’s Cell Wall Binding 
Domain (CBD) [B]
Workflow
Figure 4. Workflow. To conduct our 
analysis, we relied on freely available 
bioinformatics tools from the Max Planck 
Institute (Gabler et al., 2020). As our 
inputs were only partial sequences, two 
iterations were conducted; the first 
established a small but highly specific 
MSA of sequences closely related to Pal, 
while the second searched for homologs. 
(Gabler et al., 2020). This second MSA 
was exported to T-Coffee (Di Tommaso 
et al., 2011). Phylodendron visualized the 
.dnd file generated from T-Coffee. 
● The disparity between the trees for Pal’s two domains suggest that these domains have had 
largely separate evolutionary histories, supporting the idea that Pal is a natural chimera
● Since Pal’s EAD and CBD function well together, it is probable that homologous domains 
from the other proteins identified on these trees could be combined to produce functional 
chimeras for therapeutic purposes.
● The proteins identified in figure 5. A, shaded in green, represent promising candidates for future 
study. As Pal is itself an amidase, these proteins are likely more closely aligned to Pal’s EAD. 
Additionally, these groupings of sister taxa include proteins that illustrate lysin capabilities; the 
sister taxa most closely related to the EAD MSA includes a holin protein, which works closely 
with endolysins (Wang et al., 2000), while the sister taxa next most closely related to the EAD 
MSA includes an autolysin. 
● The proteins identified in figure 5, B, shaded in teal, represent promising candidates for future 
study as it relates to homologos of Pal’s CDB. Cell wall binding relies on the recognition of 
specific molecules present on the external surface of bacteria; choline is a unique component of 
Streptococcus cell walls (Maestro and Sanz, 2016), so the proteins identified here could be 
useful to enable chimeric endolysins to target Streptococcus.
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